Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says

Go back to Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.19 -0.03 (0.29%)
Previous Close $10.22    52 Week High $9.23 
Open $10.10    52 Week Low $1.16 
Day High $10.36    P/E N/A 
Day Low $9.75    EPS $-0.30 
Volume 4,225,464